Allergan to buy Vitae for $639m

15-09-2016

Allergan to buy Vitae for $639m

360b / Shutterstock.com

Pharmaceutical company Allergan is set to acquire clinical-stage biotechnology company Vitae Pharmaceuticals for $639 million.


Allergan, M&A, Vitae Pharmaceuticals, Mergers & Acquisitions

LSIPR